CovidChloroV1, Main, Exploration, bibRecordById, pubmed:33014379

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

Identifieur interne : 000561 ( Main/Exploration ); précédent : 000560; suivant : 000562

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

Source :

New microbes and new infections [ 2052-2975 ] ; 2021.

RBID : pubmed:33014379

Abstract

During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.

DOI: 10.1016/j.nmni.2020.100711
PubMed: 33014379
PubMed Central: PMC7525330

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000B05
to stream Main, to step Curation: 000B05

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?</title>
<author><name sortKey="Chabriere, E" sort="Chabriere, E" uniqKey="Chabriere E" first="E" last="Chabrière">E. Chabrière</name>
<affiliation wicri:level="4"><nlm:affiliation>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
<orgName type="university">Université d'Aix-Marseille</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33014379</idno>
<idno type="pmid">33014379</idno>
<idno type="doi">10.1016/j.nmni.2020.100711</idno>
<idno type="pmc">PMC7525330</idno>
<idno type="wicri:Area/Main/Corpus">000B05</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B05</idno>
<idno type="wicri:Area/Main/Curation">000B05</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000B05</idno>
<idno type="wicri:Area/Main/Exploration">000B05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?</title>
<author><name sortKey="Chabriere, E" sort="Chabriere, E" uniqKey="Chabriere E" first="E" last="Chabrière">E. Chabrière</name>
<affiliation wicri:level="4"><nlm:affiliation>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
<orgName type="university">Université d'Aix-Marseille</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">New microbes and new infections</title>
<idno type="ISSN">2052-2975</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33014379</PMID>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2052-2975</ISSN>
<JournalIssue CitedMedium="Print"><Volume>39</Volume>
<PubDate><Year>2021</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>New microbes and new infections</Title>
<ISOAbbreviation>New Microbes New Infect</ISOAbbreviation>
</Journal>
<ArticleTitle>Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?</ArticleTitle>
<Pagination><MedlinePgn>100711</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nmni.2020.100711</ELocationID>
<Abstract><AbstractText>During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.</AbstractText>
<CopyrightInformation>© 2020 Published by Elsevier Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chabrière</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>09</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>New Microbes New Infect</MedlineTA>
<NlmUniqueID>101624750</NlmUniqueID>
<ISSNLinking>2052-2975</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Azithromycin</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">remdesivir</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>06</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>18</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33014379</ArticleId>
<ArticleId IdType="doi">10.1016/j.nmni.2020.100711</ArticleId>
<ArticleId IdType="pii">S2052-2975(20)30063-9</ArticleId>
<ArticleId IdType="pmc">PMC7525330</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
        <ReferenceList><Reference><Citation>Lancet. 2020 Apr 11;395(10231):1225-1228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32178769</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mediators Inflamm. 2012;2012:649570</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22719178</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32054787</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2019 Dec 12;381(24):2293-2303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31774950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32289548</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pharmacol. 2009 Dec 25;625(1-3):220-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19836374</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):929-936</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32004427</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Provence-Alpes-Côte d'Azur</li>
</region>
<settlement><li>Marseille</li>
</settlement>
<orgName><li>Université d'Aix-Marseille</li>
</orgName>
</list>
<tree><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Chabriere, E" sort="Chabriere, E" uniqKey="Chabriere E" first="E" last="Chabrière">E. Chabrière</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000561 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000561 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33014379
   |texte=   Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33014379" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki